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Abstract
Different signal transduction pathways, i.e. Ca2- and cAMP-dependent, involved in mediating the effects of angiotensin
II (AII) were investigated separately using the short-circuit current (Isc) technique and radioimmunoassay (RIA) in a cystic
fibrosis pancreatic cell line (CFPAC-1) which exhibits defective cAMP-dependent but intact Ca2-dependent anion secretion.
The AII-induced Isc could be inhibited by the specific antagonist for AT1, losartan (1 WM), but not the antagonist for AT2,
PD123177 (up to 10 WM). The AII-induced Isc was also reduced by the treatment of the cells with a Ca2 chelator, BAPTA-
AM (100 WM), indicating a dependence of the AII-induced anion secretion on the intracellular Ca2. Treatment of the cells
with pertussis toxin (0.1 Wg/ml) or a phospholipase C (PLC) inhibitor, U73122 (5 WM), resulted in a substantial reduction in
the AII-induced Isc indicating involvement of Gi and PLC in the Ca2-dependent anion secretion. RIA measurements
showed that AII stimulated an increase in cAMP production which could be reduced by losartan, pertussis toxin and U73122
but not BAPTA-AM. In addition, inhibitors of cyclooxygenase, indomethacin (10 WM) and piroxicam (10 WM), did not have
any effect on the AII-induced cAMP production, excluding the involvement of prostaglandins. Our results suggest that both
AII-stimulated cAMP and Ca2-dependent responses are mediated by the AT1 receptor and Gi-coupled PLC pathway.
However, the AII-stimulated cAMP production in CFPAC-1 cells is not dependent on Ca2 or the formation of
prostaglandins. ß 1999 Elsevier Science B.V. All rights reserved.
Keywords: Angiotensin II; AT1 receptor; cAMP; Ca2 ; CFPAC-1 cell
1. Introduction
Angiotensin II (AII) is known to act as an active
physiologic regulator in the brain, kidney, vascular
smooth muscle and adrenal gland (for review see [1]).
A variety of signal transduction pathways can be
elicited by AII, which include phospholipase C
(PLC), phospholipase A2 (PLA2), adenylate cyclase
and direct coupling of ion channels (for reviews see
[2,3]). While AII-induced PLC-linked Ca2 mobiliza-
tion has been shown to be the dominant pathway in
many target tissues [4,5], the signaling mechanism
leading to AII-induced changes in cAMP levels is
controversial. It has been shown that AII induces a
decrease in cAMP production by the action of AT1
receptor coupled to Gi exerting an inhibitory e¡ect
on adenylate cyclase in many tissues including the
liver, pituitary gland, kidney, aorta and testis [3].
In contrast to the inhibition of adenylate cyclase by
AII in other tissues, AII has been shown to increase
cAMP levels in fetal skin ¢broblasts [6,7]. The sig-
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naling mechanism involved in mediating the e¡ect
of AII on cAMP production in these cells is not
clear.
A stimulatory e¡ect of AII on Cl3 secretion has
been noted in a number of epithelia including the
airway [8,9], intestine [10] and epididymis [11]. How-
ever, the signal transduction events involved in me-
diating the AII responses remain largely unknown.
Although an increase in cAMP production via pros-
taglandin formation has been implicated in media-
ting the AII-induced secretory responses, a Ca2-
dependence of the responses to AII has also been
observed [8,12].
Most Cl3-secreting epithelia possess both cAMP-
and Ca2-dependent regulatory pathways [13^16],
which may sometimes cross-talk with one another
[17,18]. Both increases in cAMP and Ca2 give rise
to secretory responses in many epithelial cells and,
therefore, this posts a di⁄culty in delineating the
signal transduction events underlying AII-induced se-
cretory responses. A cystic ¢brosis pancreatic duct
cell line, CFPAC-1, o¡ers an advantage in this re-
gard in that it exhibits intact Ca2-dependent but
defective cAMP-dependent anion secretion [19].
Therefore, the AII-stimulated Ca2-dependent path-
way can be studied using the short-circuit current
(Isc) technique which measures the secretory re-
sponse. On the other hand, the AII-stimulated
cAMP production can be measured by radioimmu-
noassay (RIA). The present study has made the at-
tempt to elucidate the AII-mediated signal transduc-
tion events using the CF cell line in conjunction with
these techniques.
2. Materials and methods
2.1. Materials
Iscove’s modi¢ed Dulbecco’s medium, Hanks’ bal-
anced salt solution (HBSS), trypsin, angiotensin II
(AII), pertussis toxin (PTX) and Dulbecco’s phos-
phate bu¡er saline (DPBS) were purchased from Sig-
ma (St. Louis, MO). Fetal bovine serum was from
Gibco Laboratories (New York). Sylgard resin (184
silicone slastemer kit) and silicone rubber (3140
RTV), for making the permeable supports, were pur-
chased from Dow Corning (Midland, MI). 0.45 Wm
Millipore ¢lters were obtained from Millipore (Bed-
ford, MA). BAPTA-AM and U73122 were pur-
chased from Calbiochem (La Jolla, CA). Losartan
and PD123177 were a generous gift from the Du
Pont Merck Pharmaceutical Company.
2.2. Cell culture
The culture procedure for CFPAC-1 cells was sim-
ilar to that described previously [20]. The cells were
grown in Iscove’s modi¢ed Dulbecco’s medium sup-
plemented with 10% fetal bovine serum. The cells
(1.2U106 cells/ml) were plated onto each £oating
permeable support which was made of Millipore ¢l-
ter with a silicone rubber ring attached on top of it
for con¢ning the cells. Before the cells were plated,
the permeable supports were placed carefully on to
culture medium so that they could £oat on top of the
surface. Cultures were incubated at 37‡C in 5% CO2/
95% air atmosphere, and reached con£uence in 3^4
days. Variations between batches of cultured cells did
exist. This was taken into consideration by perform-
ing independent control experiments for each batch
of cultured cells
2.3. Short circuit current measurement
The measurement of Isc has been described previ-
ously [20,21]. Monolayers grown on permeable sup-
ports were clamped vertically between two halves of
the Ussing chamber. Monolayers were bathed in
both sides with Krebs-Henseleit (K-H) solution
which was maintained at 37‡C by a water jacket
enclosing the reservoir. The K-H solution had the
following composition (mM): NaCl, 117; KCl, 4.5;
CaCl2, 2.5; MgSO4, 1.2; NaHCO3, 24.8; KH2PO4,
1.2; glucose, 11.1. The solution was bubbled with
95% O2 and 5% CO2 such that the pH of the solu-
tion was maintained at 7.4. Drugs could be added
directly to the apical or basolateral side of the epi-
thelium. Usually, the epithelium exhibited a basal
transepithelial PD which was measured by the Ag/
AgCl reference electrodes (Metrohm, Switzerland)
connected to a preampli¢er that was in turn con-
nected to a voltage-clamp ampli¢er (World Precision
Instruction, DVC-1000).
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2.4. Measurement of cellular cAMP content
Cells (4 days) grown on 24-well plates were washed
twice with physiological salt solution and incubated
at 32‡C for 10 min in the same bu¡er (0.5 ml/well)
containing IBMX (3 mM, to inhibit hydrolysis
of cAMP) either under control or other experi-
mental conditions speci¢ed in Section 3. Concen-
trated perchloric acid (10 Wl) was then added to
each well to arrest cellular metabolism and extract
cAMP; these extracts were neutralized with KOH
and stored at 318‡C until their cAMP contents
were determined by radioimmunoassay (Amersham
kit). The unit was given in fmol/107 cells. An AII
concentration of 100 WM, which was much higher
than that used to elicit Isc, was used to elicit cAMP
production, probably due to the di¡erences in the
sensitivities of the two techniques or in the two
culture conditions a¡ecting levels of receptor expres-
sion.
2.5. Statistical analysis
Results are expressed as mean þ standard error of
the mean (S.E.M.). Comparisons between groups of
data were made by Student’s unpaired t-test. A P
value of less than 0.05 was considered statistically
signi¢cant.
3. Results
3.1. Involvement of AT1 but not AT2 receptor in
mediating AII response
The primary site of action of AII was examined
using speci¢c antagonist for AT1 or AT2 receptors:
losartan or PD123177, respectively. As shown in Fig.
1, PD123177 (1 WM) did not have any signi¢cant
e¡ect on the AII-induced Isc, 1.8 þ 0.4 WA/cm2
(n = 4, Ps 0.05, as compared to the control value
of 1.5 þ 0.2 WA/cm2). On the other hand, addition
of losartan (1 WM) completely abolished the Isc re-
sponse to AII (n = 3), indicating the involvement of
the AT1 but not the AT2 receptor in mediating the
Isc response to AII.
3.2. The involvement of Gi protein and PLC in
mediating the Ca2+-dependent Isc response to AII
A previous study has demonstrated that AII eli-
cited a transient increase in intracellular Ca2 in
CFPAC-1 cells [12]. To con¢rm that the AII-induced
Isc was Ca2-dependent, the e¡ect of BAPTA-AM,
an intracellular Ca2 chelator, on the AII-induced Isc
was examined. It was found that treating the mono-
layers with BAPTA-AM (100 WM) for 45 min before
the addition of AII (0.5 WM), the AII-activated Isc
was signi¢cantly reduced from 2.60 þ 0.13 to
Fig. 1. Demonstration of the involvement of AII receptor type 1 (AT1) in mediating the Isc response. AII-induced (1 WM) Isc record-
ings in control (A), losartan-treated (1 WM) (B), and PD123177-treated (1 WM) (C) epithelia. All drugs were added to the apical mem-
brane. Note that AT1 antagonist, losartan, but not AT2 antagonist, PD123177, inhibited the AII-induced Isc response.
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0.66 þ 0.40 WA/cm2 (n = 3, P6 0.01), with a reduction
of 74.6% (Fig. 2A).
The e¡ect of a potent Gi protein inhibitor, PTX,
on the AII-induced Isc was also examined. PTX
(100 ng/ml) was added to the monolayer 24 h before
addition of AII (1 WM). The AII-induced Isc was
signi¢cantly reduced from 2.44 þ 0.08 to 1.06 þ 0.04
WA/cm2 (n = 12, 56%, P6 0.01, Fig. 2B). U73122
(5 WM), a PLC inhibitor, added 10 min prior to the
addition of AII (1 WM), induced a reduction of 58%
in the AII-elicited Isc, from 1.71 þ 0.03 to 0.71 þ 0.16
WA/cm2 (n = 4, P6 0.01, Fig. 2C).
3.3. AII-induced cAMP production
It is controversial whether AII stimulates cAMP
production in Cl3-secreting epithelia. The present
study investigated the AII-stimulated cAMP produc-
tion in CFPAC-1 cells by measuring intracellular
cAMP level directly using RIA. As shown in Fig.
3, the cAMP content in AII-treated cells was signi¢-
cantly elevated as compared to the control (P6 0.05,
n = 4). The AII-induced elevation of cAMP could be
blocked by losartan, indicating the involvement of
AT1 receptor.Fig. 2. Involvement of Gi and PLC in mediating the AII-in-
duced Ca2-dependent Isc. (A) Comparison of AII-induced Isc
responses in the absence and presence of a Ca2-chelator, BAP-
TA-AM (100 WM), treated 45 min prior to addition of AII. In-
hibition of the AII-induced Isc response by Gi inhibitor, pertus-
sis toxin (100 ng, B) and PLC inhibitor, U73122 (5 WM, C).
Cells were treated with pertussis toxin and U73122 for 24 h
and 10 min, respectively, prior to addition of AII.
Fig. 3. AT1 receptor-mediated increase in cAMP production.
AII (100 WM), added to a 24-well plate for 10 min, induced a
signi¢cant increase in cellular cAMP level (P6 0.05), which
could be abolished by AT1 antagonist, losartan (10 WM).
Fig. 4. Involvement of Gi and PLC in the AII-induced cAMP
production. Inhibition of the AII-induced cAMP production by
Gi inhibitor, pertussis toxin (100 ng/ml) and PLC inhibitor,
U73122 (5 WM, P6 0.02). Cells were treated with pertussis tox-
in and U73122 for 24 h and 10 min, respectively, prior to addi-
tion of AII (100 WM).
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3.4. E¡ect of PTX and U73122 on AII-induced
cAMP production
The e¡ect of PTX and U73122 on the AII-induced
cAMP production was also examined. As shown in
Fig. 4, the AII-induced cAMP production was sig-
ni¢cantly reduced (P6 0.02) when cells were treated
with PTX (100 ng/ml, n = 4) and U73122 (5 WM,
n = 5), 24 h and 10 min, respectively, prior to the
addition of AII (1 WM), indicating a role of Gi and
PLC in the AII-induced cAMP production.
3.5. AII-induced cAMP production was independent
of intracellular Ca2 and prostaglandin formation
The cAMP content was also measured in cells
treated with 100 WM BAPTA-AM 45 min before
addition of AII. It was found that BAPTA did not
a¡ect the AII-stimulated cAMP production (n = 4,
Fig. 5). It was also found that pretreatment of the
cells with cyclooxygenase inhibitors indomethacin
(10 WM, Fig. 6) and piroxicam (10 WM, not shown)
prior to AII stimulation did not have signi¢cant ef-
fect on the AII-induced cAMP production, excluding
the involvement of prostaglandin formation.
4. Discussion
Separate signal transduction pathways involved in
mediating the action of AII has been investigated
using CFPAC-1 cell line which lacks cAMP-depend-
ent Cl3 secretion but not cAMP production [19].
Therefore, AII-stimulated cAMP- and Ca2-depend-
ent pathways can be studied separately using di¡er-
ent techniques. Since the cAMP-dependent secretory
pathway is defective in CFPAC-1 cells, the AII-in-
duced Isc response is likely to involve Ca2 mobili-
zation as indicated by the reduction in the AII-in-
duced Isc by the treatment with BAPTA to chelate
intracellular Ca2. Although the AII-generated Ca2
transient has also been suggested to be mediated by a
Ca2 in£ux through receptor-operated Ca2 channel
in adrenal glomerulosa [22] and proximal tubular
epithelium [2,23], our previous study on CFPAC-1
cells has ruled out this possibility. The AII-induced
Isc was shown not to be dependent on extracellular
Ca2 since it was not a¡ected when extracellular
Ca2 was chelated by EGTA [12]. The present study
further suggests that the AII-induced Ca2 mobiliza-
tion involves pertussis toxin-sensitive PLC pathway
as indicated by the observation that pertussis toxin
and PLC inhibitor exerted an inhibitory e¡ect on the
AII-induced Isc. This is consistent with the observa-
tion that PLC-induced increments in intracellular
Ca2 is the major signaling pathway coupled to
AII receptors in many target tissues [3].
The signaling mechanism involved in mediating
the AII-induced cAMP production has been contro-
versial. While a decrease in cAMP production in re-
sponse to AII, which is pertussis toxin-sensitive, has
been observed in many organ tissues (for review see
[2]), AII-induced secretory responses in a number of
Cl3-secreting epithelia have been suggested to be due
to an increase in cAMP production [8^11]. AII may
stimulate cAMP production by activation of PLA2
Fig. 5. Independence of the AII-induced cAMP production on
intracellular Ca2. The cells were treated with BAPTA (100 WM)
45 min prior to addition of AII (100 WM).
Fig. 6. Independence of the AII-induced cAMP production on
prostaglandin formation. The cells were treated with indome-
thacin (10 WM) 10 min prior to addition of AII (100 WM).
BBAMCR 14452 29-3-99
H.S. Cheng et al. / Biochimica et Biophysica Acta 1449 (1999) 254^260258
thereby releasing arachidonic acid from membrane
phospholipids. Prostaglandins, which are converted
from arachidonic acid by cyclooxygenase (COX),
can then act on adenylate cyclase leading to elevation
of intracellular cAMP [24,25]. Our direct measure-
ment of cAMP using RIA on CFPAC-1 cells has
con¢rmed an elevation of cAMP production in re-
sponse to AII. However, COX inhibitors, indome-
thacin or piroxicam, were unable to block the AII-
induced cAMP elevation, excluding the involvement
of prostaglandin formation in mediating the AII-in-
duced cAMP production. This is in contrast to what
has been suggested in other epithelial cell types.
The fact that the AII-stimulated cAMP production
in CFPAC-1 cells is sensitive to pertussis toxin and
PLC inhibitor suggests that PLC-induced Ca2 re-
lease may be responsible for the AII-stimulated
cAMP production since elevation of intracellular
Ca2 has been shown to stimulate cAMP production
in a number of cell types. Cytosolic Ca2 has been
recognized as one of the modulators of the cAMP
cascade [26], through the interaction between cal-
modulin and adenylate cyclase [27]. Indirect activa-
tion of the cAMP-dependent regulatory pathway by
extracellular ATP via an increase in [Ca2]i has also
been observed in the rat epididymis [17,18]. How-
ever, the present study has ruled out this possibility
since treatment of the cells with BAPTA did not
have any signi¢cant e¡ect on the AII-induced
cAMP production. This result suggests that an alter-
native pathway may be involved in mediating the AII
e¡ect on cAMP production, detail mechanism of
which awaits further investigation.
The important ¢nding of the present study is that
both the AII-induced Ca2-dependent secretory re-
sponse and cAMP production are mediated by AT1
receptors since AT1 inhibitor, losartan, abolished
both responses. Immunolocalization of AT1 recep-
tors has been previously demonstrated in CFPAC-1
cells [12]. However, it should be noted that the con-
centrations of AII used to elicit responses in the
present study are higher than that found in human
serum. This could be due to reduced expression of
AT1 receptors in the cell line as compared to that
found in vivo. The AT1 receptors on CFPAC-1 cells
appear to be coupled to Gi and PLC to elicit further
responses. This is consistent with the ¢nding in most
target tissues that PLC is the most dominant path-
way coupled to AII receptors. What is interesting is
that this pathway could lead to di¡erent responses,
in the case of CFPAC-1 cells, Ca2-dependent secre-
tory response and cAMP production. It is expected
that the AII-induced cAMP production may elicit a
cAMP-dependent secretory response in normal pan-
creatic duct cells since cAMP plays a major role in
the regulation of pancreatic secretion [28]. AII recep-
tor-coupled PLC pathway may also generate diacyl-
glycerol release leading to activation of PKC [2]. AII-
induced PKC activation has been shown to exert an
inhibitory e¡ect on the Ca2-dependent anion secre-
tion in CFPAC-1 cells (Cheng et al., unpublished
data). Taken together, AII may play a versatile role
in modulating secretory responses in pancreatic duct
cells through the action of pertussis toxin-sensitive
PLC-coupled AT1 receptors. However, the detailed
signaling mechanism coupled to cAMP production
in response to AII remains to be elucidated.
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